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Abstract—Early degenerative changes of articular cartilage
are detected using contrast-enhanced computed tomography
(CT) with a cationic contrast agent (CA). However, cationic
CA diffusion into degenerated cartilage decreases with pro-
teoglycan depletion and increases with elevated water content,
thus hampering tissue evaluation at early diffusion time points.
Furthermore, the contrast at synovial fluid-cartilage interface
diminishes as a function of diffusion time hindering accurate
cartilage segmentation. For the first time, we employ quanti-
tative dual-energyCT (QDECT) imaging utilizing amixture of
three CAs (cationic CA4+ and non-ionic gadoteridol which
are sensitive to proteoglycan and water contents, respectively,
and bismuth nanoparticles which highlight the cartilage
surface) to simultaneously segment the articulating surfaces
and determine of the cartilage condition. Intact healthy,
proteoglycan-depleted, and mechanically injured bovine car-
tilage samples (n = 27) were halved and imaged with syn-
chrotron microCT 2-h post immersion in triple CA or in dual
CA (CA4+ and gadoteridol). CA4+ and gadoteridol parti-
tions were determined using QDECT, and pairwise evaluation
of these partitionswas conducted for samples immersed indual
and triple CAs. In conclusion, the triple CAmethod is sensitive
to proteoglycan depletion while maintaining sufficient con-
trast at the articular surface to enable detection of cartilage
lesions caused by mechanical impact.
Keywords—Triple contrast agent, Dual contrast agent, Com-
puted tomography, Contrast-enhanced computed tomogra-
phy, Post-traumatic osteoarthritis, Synchrotron microCT.
INTRODUCTION
Osteoarthritis (OA) arises due to prolonged use,
over use, or injury of an articulating joint with a
breakdown of cartilage and sclerosis of subchondral
bone causing pain, joint stiffness, swelling, and
mobility loss.1,4,32,35 Post-traumatic osteoarthritis
(PTOA) is one form of OA caused by an acute injury
of a knee joint resulting from a sport accident, a fall, or
any other source of physical trauma, and it primarily
affects younger individuals.1 However, by identifying
OA early on, the progression of the damage or injury
can be slowed down or even prevented using surgical
and pharmaceutical interventions.1,41 Thus, methods
for early diagnosis of cartilage injuries are needed.
Magnetic resonance imaging (MRI) is an important
tool in diagnosis of cartilage degeneration and PTOA.
It is sensitive to the water content in cartilage tissue,
the 3D architecture of the collagen network, and also
to proteoglycan (PG) content.27,30 However, MRI
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suffers from its relatively long in vivo imaging acqui-
sition times, high costs, and being unsuitable for
imaging patients with implanted medical devices that
are incompatible with MRI.26,30
Contrast-enhanced computed tomography (CECT)
allows imaging with high-resolution, short scan times
and, thus, with less motion artifacts at approximately
half the cost of MRI, providing an alternative imaging
method to evaluate the cartilage condition. Even
though CECT exploits ionizing radiation for extremity
imaging, the doses involved in clinical cone-beam CT
(CBCT) instruments are low with effective doses below
50 lSv.20 CECT utilizes contrast agents that enhance
the contrast at synovial fluid-cartilage interface where
the natural contrast is nearly non-existent due to sim-
ilar X-ray absorptions. In addition to providing the
contrast between cartilage and synovial fluid, contrast
agents reveal degenerative changes in carti-
lage.16,17,34,42,47,48,53 The uptake and diffused partition
of contrast agents are altered in degenerated cartilage
tissue due to degeneration-related changes including
(1) decreased cartilage fixed charge density (FCD) via
loss of PGs, (2) increased water content, and (3) dis-
ruption of the superficial collagen network.7,28 There-
fore, CECT could be used along with MRI to detect
internal articular cartilage and meniscus11,24 degener-
ation after acute injury. In addition, CECT allows
simultaneous assessment of the bony structures of the
joint.39,55
Anionic or non-ionic contrast agents are traditionally
used in CECT imaging but a recently introduced ca-
tionic contrast agent (CA4+) shows superior sensitivity
at diffusion equilibrium to detect tissue PG con-
tent.2,24,25 Despite this, the widespread use of CA4+ is
hindered due to suboptimal performance at imaging
times during early diffusion (0–2 h from contrast agent
administration).18,22 The distribution of cationic con-
trast agents with articular cartilage is proportional to
PG content as the negative fixed charge carried by PG
molecules attracts the positively charged contrast
agents. However, especially in the early stage of diffu-
sion, the diffusion of cationic contrast agent is also
controlled by degeneration-related factors having
opposite effects; the loss of PGs decreases the diffusion
of cationic contrast agentwhile increase inwater content
and decrease in steric hindrance (i.e., physical diffusion
barrier of the tissue caused by collagen network archi-
tecture and PGs in the matrix) increase the diffusion.
This shortcoming can be overcome using a quantitative
dual-energy CT technique (QDECT).5
QDECT utilizes a mixture of a cationic, iodinated
contrast agent (e.g., CA4+)2,16 and a non-ionic,
gadolinium-based contrast agent (e.g., gadoteridol).
As mentioned above, CA4+ possesses a high affinity
for PGs. Gadoteridol, on the other hand, as an un-
charged molecule distributes into cartilage according
to water content and steric hindrance. Thus, by nor-
malizing (e.g., dividing) the cationic contrast agent
partition in the cartilage with that of the non-ionic
contrast agent, the effects of water content and steric
hindrance on the diffusion of the cationic contrast
agent can be limited.5,12,46 Simultaneous determination
of the uptake of the both contrast agents within car-
tilage requires imaging with two X-ray energies. In
QDECT, these energies are selected based on element
specific absorption k-edge energies of iodine (33.2 keV)
and gadolinium (50.3 keV).
Current CECT of a knee joint requires two subse-
quent CT scans acquired immediately (arthrography)
and 30 min to 2 h (delayed arthrography) after the
intra-articular injection of contrast agent.22,23,39 The
first scan enables accurate segmentation of articulating
surface and lesions while the latter scan provides
information on internal changes in cartilage tissue and
properties related to the initiation of PTOA by exam-
ining the diffusion of the contrast agent in the tissue.
The two scans are required since the segmentation of
articulating surface and delineation of lesions is diffi-
cult from the latter scan owing to diffusion-related loss
of image contrast at the synovial fluid-cartilage inter-
face. In addition, no interpretation of the cartilage
tissue properties is made from the first scan as the
contrast agent has not had sufficient time to diffuse
into cartilage. Acquiring two images is logistically
burdensome and doubles the radiation dose to a pa-
tient. Our recent findings have shown that bismuth
nanoparticles (BiNP) can be utilized to overcome this
problem of requiring two CT scans.45 Due to their size,
BiNPs are too large to diffuse into the cartilage tissue,
and, thus, remain at the synovial space.45 Using the
QDECT with BiNPs and ioxaglate, only the delayed
arthrography is required since both the segmentation
and evaluation of the cartilage condition can be done
simultaneously.
In this study, we introduce for the first time a triple
contrast agent composed of three contrast agents: (1)
cationic, iodine-based CA4+, (2) non-ionic, gadolin-
ium-based gadoteridol, and (3) BiNP suspension.
Using the triple contrast agent, we hypothesize that the
PG and interstitial water contents in articular cartilage
will be simultaneously and quantitatively assessed
based on CA4+ and gadoteridol distributions within
tissue (Fig. 1). Further, we hypothesize that accurate
segmentation of the articulating surface from the de-
layed CT arthrography images will be facile as BiNPs
maintain good contrast between the articulating sur-
face and immersion bath. To address these hypotheses,
intact healthy, proteoglycan-depleted, and mechani-
cally injured cartilage samples are evaluated using
synchrotron microCT as it provides fast tomographic
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imaging with monochromatic X-ray spectra and high
resolution.51
MATERIALS AND METHODS
Intact bovine patellae (N = 9) were dissected from
skeletally mature stifle joints obtained from a local
butcher (Savo-Karjalan liha Oy, Finland) and stored
in 2 20 C wrapped in phosphate buffered saline
(PBS) soaked gauze in a zip lock bag until sample
preparation (a detailed flowchart of the sampling and
experiments are presented in Fig. 2). Prior to the
sample preparation, the patellae were thawed in a bath
of PBS in room temperature, and three adjacent
osteochondral plugs (n = 27, d = 7 mm) were ex-
tracted from the upper lateral quadrant of the patellae.
Osteochondral plugs were trimmed to include 1 mm of
bone underneath the cartilage.8 The osteochondral
plugs were divided into three sample groups: (1) intact,
(2) PG-depleted, and (3) mechanically injured. The
latter two served as models of cartilage degeneration
and acute injury, respectively. Early-stage OA involv-
ing PG-loss can be mimicked by treating the cartilage
with proteolytic enzymes.3,6,10,29,38,44,45 Nearly com-
plete PG-depletion in sample group 2 was achieved by
immersing the samples in PBS supplemented with
trypsin (0.5 mg/mL, Sigma-Aldrich, MO, USA) for
15 h at 37.5 C, 5% CO2 atmosphere in an incuba-
tor.38,45 Subsequently, trypsin-treated samples were
immersed in PBS for 2 h at 7 C to suppress the
degradation process. To mimic disruption of the car-
tilage surface (related to PTOA) and cartilage lesion
after the physical trauma caused by impact, a
mechanical injury was induced to cartilage.15 This
damage was accomplished using a custom-made drop
tower with a stainless-steel impactor (500 g) having a
flat polished face.21,45 The impactor was dropped on
the sample from the height of 20 cm21,45 creating
cracks with varying depth and size on the articular
surface. After the impact, the impactor was immedi-
ately lifted from the articular surface, and the samples
were allowed to recover in PBS for 2 h to prevent creep
deformation. Then, the samples were imaged with a
double contrast agent (mixture of ioxaglate and
BiNPs) as described in our previous study,45 and the
contrast agent was subsequently washed out (by
immersing the samples in PBS for 2 h) and the samples
were frozen (2 20 C) in a zip lock bag as immersed in
fresh PBS. Prior to the measurements for this study,
the samples were thawed and halved (Fig. 2). The first
half was used in digital densitometry (DD) measure-
ments to determine the optical density of Safranin-O
stained sections (i.e., the PG content) of the sample
while the second half was halved again for pairwise
evaluation of dual and triple contrast agents. The sides
and the bottom of the quarter osteochondral samples
intended for synchrotron microCT imaging were
carefully sealed with cyanoacrylate (Loctite, Henkel
Norden AB, Dusseldorf, Germany) and stored at2 20
C until the measurements. The quarter samples were
measured at synchrotron microCT beamline (X02DA
FIGURE 1. The uptake of cationic contrast agent (CA4+) is proportional to the fixed charge density conferred by proteoglycans
(PGs). Healthy cartilage has a high PG content, and thus the uptake of cationic contrast agent (CA4+) is also high. In degenerated
cartilage the uptake of cationic contrast agent into cartilage matrix is limited due to decreased PG content. On the other hand, as
the tissue degenerates, the tissue water content increases and steric hindrance decreases allowing more contrast agent
molecules (both CA4+ and gadoteridol) to penetrate the tissue. Bismuth nanoparticles (average diameter of 194 nm) are too large
to be able to diffuse into either healthy or degenerated cartilage, thus maintaining the contrast at the articulating surface at all
diffusion time points.
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TOMCAT beamline of the Swiss Light Source, Paul
Scherrer Institut (PSI), Villigen, Switzerland).50
BiNPs were prepared by ball-milling (Planetary
Micro Mill, Pulverisette 7, Fritsch GmbH, Germany)
bismuth(III) oxide powder in two standard milling
bowls each containing 10 g of powder, 70 g of 1 mm
milling balls, and 40 mL of distilled water. The bis-
muth oxide powder was milled in 10 min cycles at a
speed of 700 rpm with a cooling time of 15 min in
between each milling round resulting in a total milling
time of 2 h. After milling, 0.5 kDa PEG-silane (2-
[Methoxy(polyethyleneoxy)9-12propyl]trimethoxysi-
lane, tech-90, Fluorochem, Old Glossop, UK) was
added to the milled NP solution to improve the sta-
bility with the mass ratio of PEG-silane to BiNP being
1:6. Next, the mixture was heated up to 260 C and
maintained at a constant temperature for 2.5 h in a
protective N2 atmosphere. Finally, to remove remain-
ing unreacted chemicals, the solution was washed with
ethanol three times via centrifuge separation
(10,000 rpm, 10 min) and ultrasound re-dispersion.
The obtained PEG-coated BiNPs were stored in etha-
nol until the synchrotron microCT measurements. The
BiNPs possess a mean diameter of 194 nm and a sur-
face charge of 2 3.5 mV (Zetasizer Nano ZS, Malvern
Instruments Ltd., Malvern, UK). Prior to measure-
ments, the BiNPs were separated from the solution by
centrifuging the BiNP-ethanol solution at 10,000 rpm
for 5 min. Then, the NPs were dispersed in distilled
water using ultrasound. Subsequently, the centrifuging
and re-dispersion process was repeated similarly to
ensure that all ethanol was completely washed out
from the solution. After the preparation, the NPs were
immediately mixed with the other contrast agents and
the samples were immersed in the mixture.
Two contrast agent mixtures were prepared; a dual
contrast agent and a triple contrast agent. The isotonic
(~ 308 mOsm/kg) dual contrast agent composed of a
mixture of iodinated cationic contrast agent (CA4+,
q = + 4, M = 1499.88 g/mol) and gadolinium-
based, electrically neutral contrast agent (gadoteridol,
q = 0, M = 558.69 g/mol, ProHanceTM, Bracco
Diagnostic Inc., Monroe Twp., NJ, USA) was diluted
in PBS. In the dual contrast agent, the iodine (I) con-
centration was 5 mg I/mL and gadolinium (Gd) 10 mg
Gd/mL. Moreover, the solution was supplemented
with proteolytic inhibitors [5 mM ethylenediaminete-
traacetic acid (EDTA, VWR International, France)
and 5 mM benzamidine hydrochloride hydrate (Sig-
ma-Aldrich Inc., St Louis, MO, USA)] to suppress
general protein degradation in cartilage tissue. Triple
contrast agent was otherwise similar to dual contrast
agent but BiNPs, with the concentration of 10 mg/mL
of BiNPs, were added to the solution. The stability of
the BiNPs in the triple contrast agent was analyzed via
monitoring the particle diameter change during dif-
ferent time periods. The results (Fig. 3) indicate that
the BiNPs are stable in the mixed triple contrast agent
for more than 24 h.
Synchrotron-based microCT imaging was per-
formed with a third-generation synchrotron-based X-
ray source. MicroCT images were acquired by com-
bining 1:1 magnifying visible light optics microscope
(Optique Peter, France), a 300 lm thick scintillator
(LuAg, CRYTUR spol.s.r.o., Czech Republic), and a
scientific complementary metal–oxide–semiconductor
(sCMOS) detector (pco.Edge 5.5, PCO AG, Ger-
many). Two monochromatic X-ray energies of 32 and
34 keV from both sides of iodine k-edge (33.2 keV)
were selected to maximize the difference in the mass
attenuation coefficients of iodine (CA4+). A double-
multilayer monochromator with a spectral bandwidth
of about 2–3% was used. Imaging geometry resulted in
an isometric voxel size of 6.5 9 6.5 9 6.5 lm3 and a
field of view (FOV) of 16.6 9 3.5 mm2. The radiation
FIGURE 2. Workflow of the sample preparation and
processing protocol. The samples were thawed for previous
experiments described in Saukko et al.45 Bovine
osteochondral samples were immersed in dual (mixture of
CA4+ and gadoteridol) or in triple (mixture of CA4+,
gadoteridol and bismuth nanoparticles) contrast agents for
2 h before the synchrotron microCT (lCT) measurements.
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exposure was minimized by applying an off-beam
alignment system.33
Before measuring the bovine samples, a set of
CA4+ and gadoteridol phantoms with varying con-
centrations in distilled water were measured with both
X-ray energies to determine the mass attenuation
coefficients of the contrast agent compounds. The io-
dine concentrations in CA4+ phantoms were 3, 6, 12,
18, 24, 30, and 36 mg I/mL and gadolinium concen-
tration in gadoteridol phantoms 6, 9, 12, 15, and 18 mg
Gd/mL. Based on these calibration measure-
ments, CA4+ and gadoteridol concentrations within
the cartilage tissue can be calculated using QDECT. To
validate this technique, contrast agent mixture phan-
toms having iodine/gadolinium concentrations of 3/18,
6/16, 10/14, 16/12, 20/10, 26/8, 32/6, and 40/3 mg/mL
were imaged (Fig. 4).
Prior to the contrast agent immersion, non-contrast
images of all quarter cartilage samples (n = 54) were
acquired in the air with 32 and 34 keV X-ray energies.
After acquiring the baseline image, the quarter sample
pairs obtained from the same patellae were immersed
either in dual (n = 27) or triple (n = 27) contrast
agent bath (24 mL, ‡ 100 times the cartilage volume)
at + 7 C. After 2 h, all the samples (n = 54) were
imaged three times, first with 34 keV X-ray beam, then
with 32 keV, and again with 34 keV, to minimize the
effect of ongoing diffusion by averaging the two
34 keV images. The acquisition time was approxi-
mately 129 s with time difference between the subse-
quent acquisitions being 331 s on average. Highly
optimized algorithm based on Fourier methods was
used in image reconstruction.36 The measurement set
up is explained in more detail in our previous paper by
Saukko et al.46
The absorbed radiation dose on the samples was
evaluated by measuring the X-ray flux with calibrated,
passivated, and implanted planar silicon (PIPS)
diodes.33 The measured X-ray flux for 32 keV was
9.8 9 1010 photons/mm2/s and for 34 keV 1.0 9 1011
photons/mm2/s. To calculate the absorbed dose, the
cartilage samples were modelled as soft tissue (ICRU-
44)56 according to the X-ray mass energy-absorption
coefficient from the NIST database.14 The presence of
contrast agent was neglected. The absorbed doses were
0.47 Gy for 32 keV and 0.43 Gy for 34 keV.
The articulating surface and bone-cartilage interface
at each time point were defined manually using a seg-
mentation software (Seg3D, version 2.2.1, 2015,
University of Utah, Salt Lake City, UT, USA) along
a protocol described in more detail in our previous
paper.45 A cylindrical volume of interest (VOI,
d = 1313 lm, h = cartilage thickness) was delineated
FIGURE 4. The synchrotron microCT measured CA4+ (3) and gadoteridol (+) concentrations with dual energy technique, and the
real concentrations (solid line) within mixture phantoms. The relative mean error in measured concentrations were 1.5 and 2.6% for
CA4+ and gadoteridol, respectively.
FIGURE 3. The stability of the bismuth nanoparticles was
determined by measuring the particle diameter after the CA4+
and gadoteridol were added to the triple contrast agent
mixture. The particle diameter change was not significant
within 24 h according to the statistical analysis with the One-
way ANOVA model (p > 0.05), as compared with the original
particle diameter.
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from the center of the bovine sample using a custom-
made MATLAB (R2017b, The MathWorks, Inc.,
Natick, MA, USA) code. The cracks in the mechani-
cally injured samples were removed by thresholding.
Then, the depth-wise X-ray attenuation profiles were
calculated, and the profiles obtained from the 34 keV
acquisitions were averaged to minimize the error
caused by ongoing diffusion. The native X-ray atten-
uation profiles of the cartilage obtained from the non-
contrast-enhanced images were subtracted from the
contrast-enhanced profiles. Finally, the depth-wise io-
dine (CA4+) and gadolinium (gadoteridol) partitions
within cartilage were determined in two steps: (1) the
mass attenuation coefficients of iodine and gadolinium
were determined based on the CA4+ and gadoteridol
phantoms; (2) Beer-Lambert law and Bragg’s rule were
used to calculate the concentrations of iodine and
gadolinium partitions in the cartilage43:
aE ¼ lI;ECI þ lGd;ECGd; ð1Þ
where aE is the X-ray attenuation with energy E, lI,E
and lGd,E are the mass attenuation coefficients, and CI
and CGd the concentrations of iodine (I) and gadolin-
ium (Gd), respectively. By applying two energies (32
and 34 keV), the concentrations of iodine and
gadolinium at each point can be solved as follows:
CI ¼
a34 keVlGd;32 keV  a32lGd;34 keV
lI;34 keVlGd;32 keV  lI;32 keVlGd;34 keV
ð2Þ
CGd ¼
a32 keVlI;34 keV  a34 keVlI;32 keV
lI;34 keVlGd;32 keV  lI;32 keVlGd;34 keV
: ð3Þ
In the analysis, the decrease of the contrast agent
concentrations in the surrounding bath due to diffu-
sion was taken into consideration. Moreover, the
determined iodine (CA4+) partition profiles were
normalized with that of gadolinium (gadoteridol) to
reduce the effect of water content and steric hindrance
on CA4+ partition and, thereby, to improve the
detection of PG content. Further, X-ray attenuation
profiles through cartilage depth were divided into
superficial (0–10%), middle (10–40%) and deep (40–
100%) zones, 0% denoting the articulating surface and
100% the cartilage-bone interface, to compare the
contrast agent partition values between the groups
(reference, PG-depleted and mechanically injured) and
to the corresponding PG distribution (optical density)
in each zone.
DD measurements were performed on the second
half of the samples to calculate the optical density
(OD) by first thawing and subsequently fixing the
samples in 10% formalin. Then, ascending series of
ethanol and EDTA were used to dehydrate and
decalcify the samples, respectively. The samples were
embedded in paraffin and cut into 3 lm thick sections.
Subsequently, the paraffin was removed, and the
samples were stained with Safranin-O which is a ca-
tionic dye stoichiometrically binding to the negative
fixed charge in cartilage.19 To examine the spatial FCD
distribution in the cartilage, the optical density (i.e.,
PG distribution) of the samples were measured using
quantitative DD. The equipment included a light
microscope (Nikon Microphot-FXA, Nikon Co., Ja-
pan) equipped with a monochromatic light source
(wavelength 492 ± 8 nm) and a 12-bit CCD camera
(ORCA-ER, Hamamatsu Photonics K.K., Japan). The
system was calibrated using neutral density filters
(Schott, Germany) covering OD range from 0 to 2.6.
An average of three sections was used to calculate the
depth-wise PG content.
Pearson correlation was used to determine the sta-
tistical dependency between the contrast agent parti-
tions and PG distribution within cartilage zones. The
significance of enhancement, established by normal-
ization, to CA4+ correlations with PG distribution
was tested based on Steiger.52 In addition, the signifi-
cance of the differences in contrast agent partition
values between reference samples and conditioned
samples were obtained with Wilcoxon signed-rank test.
The difference was defined to be significant when
p < 0.05. The statistical analyses were conducted
using SPSS (v. 25.0 SPSS Inc., IBM Company, Ar-
monk, NY, USA).
RESULTS
The triple contrast agent enhanced the image con-
trast at the bath-cartilage interface and allowed accu-
rate segmentation of the articulating surfaces at the 2-h
time point (Fig. 5). Visual detection of cracks on the
cartilage surface of the mechanically injured samples
was possible with use of the BiNPs. With the dual
contrast agent, the visualization of the bath-cartilage
interface and cracks on the cartilage surface was lim-
ited. The stability of the BiNPs was measured after
mixing the BiNPs, CA4+, and gadoteridol, by deter-
mining mean particle diameter at the 2-h time point
(193 ± 2 nm; Fig. 3) as well as the 7 and 24-h time
points. No change in particle diameter was noted at the
7-h time point, however at the later time point, the
diameter of BiNPs slightly increased to 205 ± 4 nm.
Even though particle diameter at 24 h was increased,
the change was not significant according to the statis-
tical analysis with the One-way ANOVA model
(p > 0.05) as compared with the original particle
diameter. The nanoparticles possessed good colloidal
stability in aqueous solution due to the coating with
polyethylene glycol (PEG).40
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The uptake of CA4+ into intact healthy reference
samples was higher as compared with PG-depleted
samples, especially at the superficial and middle zones
where the difference was significant (Table 1; Fig. 6). A
significant difference in CA4+ uptake between intact
reference and mechanically injured samples was
observed in the superficial and deep zones with the dual
contrast agent and in the superficial zone with the triple
contrast agent. The normalization of CA4+ partition
with that of gadoteridol increased the difference
between the intact reference and PG-depleted and
mechanically injured samples. In the PG-depleted sam-
ples, gadoteridol uptake was significantly higher in all
zones for the dual contrast agent while it was greatest in
middle and deep zones for the triple contrast agent. In
the mechanically injured samples, gadoteridol uptake
was greatest inmiddle and deep zones for the dual agent,
and in all zones with triple agent. A statistically signifi-
cant (p < 0.05) difference between the full thickness
partitions of the dual and triple contrast agents were
observed forCA4+(reference andmechanically injured
samples), normalized CA4 + (mechanically injured
samples), and gadoteridol (reference and mechanically
injured samples; Table 1). Statistically significant cor-
relations (0.504 < r < 0.766, 0.0001< p < 0.007)
were found between CA4+ partition and PG distribu-
tionwith both contrast agent mixtures in superficial and
middle zones. Gadoteridol partition correlated signifi-
cantly (2 0.442 < r < 2 0.428, 0.021< p < 0.026)
with PG distribution only in the deep zone and whole
cartilage thickness with dual contrast agent. The nor-
malization significantly improved the correlation
between the CA4+ and PG distribution in the middle
zone with both contrast agents.
FIGURE 5. Safranin-O stained histological sections and synchrotron microCT (32 keV) images (average of five consecutive
6.5 lm thick slices) of the intact reference, PG-depleted, and mechanically injured samples imaged with dual and triple contrast
agents 2 h after the contrast agent immersion. Articulating surface and cracks are better visualized with the triple contrast agent
owing to better contrast induced by bismuth nanoparticles (BiNPs) that, due to their size, are too large to diffuse into cartilage. The
enhancement caused by the BiNPs was similar for 34 keV synchrotron microCT images (not shown). CT images were selected to
closely match the locations of the histological sections.
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FIGURE 6. Mean (n = 9 for each sample group) depth-wise partitions of CA4+, normalized CA4+, and gadoteridol in cartilage 2 h
after the immersion in dual or triple contrast agent. |——| represents the statistically significant (p < 0.05) difference between the
contrast agent partition in the intact reference and proteoglycan (PG)-depleted (turquoise) or mechanically injured (red) sample
and statistically significant (p < 0.05) correlation with PG distribution (dark green) within the superficial, middle, and deep zones.
Partition is defined as contrast agent concentration in the cartilage divided by the concentration of the immersion bath. 0 denotes
the articulating surface and 1 the cartilage-bone interface.
TABLE 1. Full thickness contrast agent partitions, standard deviations and optical density (OD) for intact reference, PG-depleted
and mechanically injured samples.
Contrast agent Reference PG-depleted Mechanical 
injury
CA4+ Dual 111.7 ± 28.8 86.3 ± 12.1 143.7 ± 35.6
Triple 129.8 ± 34.8 88.5 ± 9.6 137.3 ± 37.7
Normalized 
CA4+
Dual 152.3 ± 26.2 100.1 ± 11.6 182.5 ± 29.1
Triple 163.1 ± 53.2 92.1 ± 8.8 146.4 ± 30.5
Gadoteridol Dual 64.8 ± 9.5 77.6 ± 10.5 77.6 ± 12.0
Triple 79.4 ± 10.2 91.2 ± 11.3 93.1 ± 14.9
OD 1.52 ± 0.26 0.41 ± 0.25 1.16 ± 0.22
Statistically (p < 0.05) significant differences between the contrast agent partitions for dual and triple contrast agents are marked with square
brackets].
BIOMEDICAL
ENGINEERING 
SOCIETY
Triple Contrast Computed Tomography 563
DISCUSSION
This study evaluates the potential of CECT using
the triple contrast agent for assessment of cartilage
degeneration and acute injury. We hypothesize that the
triple contrast agent will provide a solution for two
shortcomings of the current technique. Firstly, simul-
taneous loss of PGs and decrease in steric hindrance in
degenerating cartilage afford opposite effects on
CA4+ diffusion, leading to a loss of diagnostic sensi-
tivity at early, clinically feasible, time points. Secondly,
contrast at the synovial fluid-cartilage interface is
diminished due to contrast agent diffusion into the
cartilage, thus limiting detection of this tissue bound-
ary. Accordingly, the triple contrast agent will yield
enhanced diagnostic sensitivity for articular cartilage
injury and evaluation of cartilage degeneration with
lower radiation dose.
Higher CA4+ uptake was seen in reference carti-
lage samples compared with PG-depleted samples
using the dual and triple contrast agents in the super-
ficial and middle zones. During 2 h of diffusion, only a
minor portion of the contrast agent molecules have
reached the deepest parts of the cartilage and therefore,
almost similar CA4+ uptake of contrast agent in in-
tact and PG-depleted samples is observed (Fig. 6). In
addition, regardless of the trypsin treatment, some PG
molecules remain in the deepest cartilage in the PG-
depleted samples. Normalization of CA4+ partition
with that of gadoteridol, diminishing the effect of
variation in water content on the contrast agent dif-
fusion, increases the difference between the CA4+
partitions of PG-depleted and reference samples. Since
nearly all PGs were depleted during the trypsin treat-
ment, the PG-depleted samples bound less CA4+
compared with the intact reference samples with higher
PG concentrations in the superficial zone. However, as
in this study, imaging was conducted at 2 h after the
diffusion afar from the diffusion equilibrium. The
contrast agent distribution along the cartilage thick-
ness is not equivalent to that of the PG content
(Fig. 5). These results are in agreement with litera-
ture.2,11,24,54
The uptake of CA4 + into mechanically injured
samples, when compared with the intact reference
samples, was lower near the articulating surface of the
cartilage and higher in deeper with both contrast agent
mixtures. This is most probably due to cracks (having
exactly 100% partition for CA4+ and gadoteridol) on
the cartilage tissue caused by the mechanical impact.
Even though the cracks are mostly removed by
thresholding, a small margin was left to ensure that no
data within cartilage was excluded. Therefore, small
parts of the cracks with lower CA4+ partition, when
compared with the tissue next to it, are averaged to
mean partition in the superficial zone, causing the
lower partition than in reference samples at the sur-
face. However, the cracks also facilitate CA4+ diffu-
sion, through the crack walls, into the cartilage,
therefore increasing the diffusion surface area, while
the diffusion into the reference samples occurs only
through the articulating surface.
The uptake of gadoteridol into PG-depleted and
mechanically injured samples is higher compared to
intact reference samples. This result is a consequence
of reduced steric hindrance due to depletion of PGs,
disruption of collagen network, and increased water
content due to mechanical impact.9,21 These changes
increase the tissue porosity allowing easier penetration
of the contrast agent molecules. As the cracks in the
mechanically injured samples increase the surface area
for diffusion, the uptake of gadoteridol and the
gadoteridol partition also increase.
The shapes of the mean (N = 9) partition profiles
of CA4+ and gadoteridol are similar when using triple
or double contrast agents. However, statistically sig-
nificant (p < 0.05) difference between dual and triple
contrast agents’ full thickness partitions were found in
the reference and mechanically injured samples. The
contrast agent partitions for triple contrast agent were
slightly higher in the reference and mechanically in-
jured samples (Table 1). These higher partitions of the
triple contrast agent’s CA4+ and gadoteridol are most
probably due to reconstruction-based increase (in the
superficial and middle zones) in attenuation near the
articulating surface where the attenuation level dras-
tically changes when the triple contrast agent is used.
Moreover, the different halves of the samples were
used for dual and triple contrast agent imaging causing
minor variation in the cartilage height, due to natural
curvatures of the cartilage surfaces leading to a minor
difference in the contrast agent partitions. Thus, the
significantly lower normalized CA4+ partition for the
mechanically injured samples was observed as the
slightly lower CA4+ partition was normalized with
significantly higher gadoteridol partition. We have
ruled out the possibility of BiNPs (particle diame-
ter = 193 nm) to diffuse into cartilage and being
responsible for these differing results since BiNPs re-
mains stable for 24 h (Fig. 3) and do not diffuse into
cartilage having pore size around 6 nm.31,45,49 As the
CA4+ and gadoteridol partitions are slightly higher
with the triple contrast agents, BiNPs are not inter-
fering with the diffusion of the other contrast agents. A
similar result was observed by Saukko et al. with an-
other dual contrast agent (ioxaglate and BiNPs).45
In the triple contrast agent, the BiNPs enhanced the
contrast between the cartilage tissue and the sur-
rounding contrast agent bath. This enhancement sig-
nificantly improved the delineation of the articulating
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surfaces and the detection of surface lesions caused by
a mechanical impact compared with dual contrast
agent (Fig. 5).
The present triple contrast imaging protocol has
three limitations. First, QDECT is based on two image
acquisitions conducted simultaneously using two dif-
ferent energies. The energies are selected based on the
attenuating elements of the contrast agents, and, the
selected energies must straddle both sides of the other
elements’ k-edge (in this study we chose iodine,
33.2 keV). In the present study, imaging with two en-
ergies was performed consecutively with in average
331 s time difference between acquisitions. This dif-
ference allows the progression of diffusion within
cartilage violating the basic assumption of simultane-
ous dual energy imaging. However, as imaging was
performed first with 34 keV X-ray beam, then with
32 keV, and again with 34 keV, the effect of ongoing
diffusion on results was minimized by averaging the
34 keV images. Further, as the image acquisition took
approximately 129 s, the obtained attenuation profiles
are expected to represent an average over the scan time
rather than an exact value at a specific imaging time
point. Regardless of this, the results and conclusions
are expected to contain no major errors as samples
were imaged using the same imaging protocol and as
the sample thicknesses were relatively similar. Fur-
thermore, as dual-energy and photon-counting CT
scanners become more available, the execution of
QDECT technique will become easier and straight-
forward. Second, the observed minor agglomeration of
the BiNPs indicates that BiNPs and the triple contrast
agent mixture needs to be prepared just before the
immersion/injection, as was done in this study. Third,
the technique requires the administration of three
contrast agents, and the safety of this combined for-
mulation will need to be addressed. Alone, gadoteridol
has been widely used in the clinic, and it is known to
possess a very low incidence (1.4%)13 of acute adverse
reactions. A preliminary study reported the safety of
CA4+ on articulating tissues.53,54 Evaluation of the
safety regarding the use of BiNPs is still ongoing.
However, bismuth is known to exhibit low toxicity.37
To conclude, the triple contrast method enables
simultaneous evaluation of PG and water contents,
providing information on degenerative changes of
articular cartilage. Furthermore, triple contrast agent
allows, for the first time, the evaluation of cartilage
condition and accurate segmentation of articulating
surfaces simultaneously at 2 h post administration.
Moreover, taking the advantage of monochromatic X-
ray beams with high resolution offered by a syn-
chrotron microCT system, artefacts and limitations
related to conventional CT systems are minimized in
determining the degenerative state of cartilage.
Therefore, this method may enable accurate evaluation
of joint health with one image acquisition. As the dual
contrast technique with CA4+and gadoteridol suc-
cessfully images articular cartilage and provides an
assessment of proteoglycan and water content in
human articular cartilage with a clinical full-body
CT,12 we are optimistic that the triple contrast method
will perform well also in the clinical setup. However,
further studies with ex vivo knee joints at early diffu-
sion time points and using a full-body CT device are
needed to optimize the imaging parameters and
imaging time point. These experiments are important
in order to reveal the clinical potential of the triple
contrast method to detect acute injuries and PTOA
related changes in cartilage condition. An extensive
time series can be conducted with ex vivo setup, as the
patient dose is not limiting factor, and with clinical CT
system the image acquisition is very fast (< 1 min).
Finally, the optimal imaging time point needs to be
confirmed with in vivo measurements.
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